On May 9, 2025, Tivic Health Systems, Inc. signed an agreement with Scorpius BioManufacturing to manufacture their drug Entolimod, with a total investment of approximately $4.1 million, including around $2.4 million in service fees. This event is significant for the company as it marks a key partnership in drug manufacturing.